Baricitinib NEW

Million pharm is manufacture and supply Baricitinib as API (Active Pharmaceutical Ingredient), including baricitinib intermediates.

Baricitinib, (api power manufactured by Million pharm) sold under the brand name Olumiant among others, is an immunomodulatory medication used for the treatment of rheumatoid arthritis, alopecia areata, and COVID-19

In June 2022, U.S. FDA approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata. Alopecia areata is a disorder that often appears as patchy baldness and affects more than 300,000 people in the U.S. every year.  

Baricitinib is a Janus kinase (JAK) inhibitor that reversibly inhibits Janus kinase 1 with a half maximal inhibitory concentration (IC50) of 5.9 nM and Janus kinase 2 with an IC50 of 5.7 nM.